Preferred Label : ProMark Proteomic Prognostic Test;
NCIt related terms : ProMark Proteomic Prognostic Test for Prostate Cancer; ProMark;
NCIt definition : A proprietary tissue-based test that uses multiplex immunofluorescent staining with
monoclonal antibodies to provide a personalized prediction for prostate cancer aggressiveness.
It detects an 8-protein signature (DERL1, CUL2, SMAD4, PDSS2, HSPA9, FUS, pS6 (phosphorylated
S6), YBOX1).;
NCI Metathesaurus CUI : CL971092;
Origin ID : C162576;
UMLS CUI : C5206659;
Semantic type(s)
- concept_is_in_subset
